𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate

✍ Scribed by YI-HSIUNG LIN; CHIA-YIH LIU; MEI-CHUN HSIAO


Book ID
108961897
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
39 KB
Volume
59
Category
Article
ISSN
1323-1316

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prolactin fluctuation over the course of
✍ Norio Yasui-Furukori; Hanako Furukori; Norio Sugawara; Shoko Tsuchimine; Akira F πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract Hyperprolactinemia is a frequent consequence of treatment with some antipsychotic agents. Although prolactin secretion varies over the course of a day and during psychological circumstances, there is little information in the literature regarding the time dependence of the prolactin res

Association study of polymorphisms in In
✍ Arun K. Tiwari; Clement C. Zai; Herbert Y. Meltzer; Jeffrey A. Lieberman; Daniel πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract ## Objective Atypical antipsychotic drugs, in particular clozapine and olanzapine, influence cellular lipogenesis and are associated with metabolic side effects including weight gain. Insulin induced gene 2 (INSIG2) mediates feedback control of lipid synthesis and polymorphisms in the

Effect of augmented atypical antipsychot
✍ Ho-Jun Seo; Young-Eun Jung; Young Sup Woo; Tae-Youn Jun; Jeong-Ho Chae; Won-Myon πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

## Abstract ## Objective The extent of weight changes in depressed patients who use atypical antipsychotics (AAP) as augmentation could not be easily predicted due to weight related symptoms of depression and the interaction with antidepressants which have weight reducing effects. ## Methods Pat